Tag Archive for: neurovascular disease

Anaconda Biomed Secures $56 Million Financing from New and Existing Investors

Proceeds used to complete ongoing ATHENA pivotal IDE study, continue product development, and secure global regulatory approvals for neurovascular portfolio   BARCELONA, Spain and MARIN, Calif. – September 23, 2026 – Anaconda Biomed, a medical technology company developing a next-generation portfolio of novel thrombectomy catheters based on its core funnel catheter technology platform, today announced […]

© Optimum Strategic Communications.